Its antioxidant effects against MASLD were likely mediated through activation of the PI3K/AKT pathway with subsequent Nrf2 nuclear translocation, which increased expression of HO-1 and NAD(P)H quinone oxidoreductase 1 (NQO1) (137). Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.